Abstract
Acute myocardial infarcts (AMI) are typically discriminated with T2-STIR imaging, albeit with limited specificity. Guided by the association that T2-STIR images identify AMI territories on the basis of edema-related T2 changes, even some of the recently proposed improvements have relied on preferential sensitization of magnetization to T2-weighting. However, whether T2-STIR imaging itself may also be sensitive to other sources of contrast have not been fully investigated.
Introduction
T2-weighted Short Tau Inversion Recovery (T2-STIR) MRI is the clinical standard for identifying myocardial edema following an acute myocardial infarction (AMI). Traditionally, the hyperintense (bright) signal in these images has been attributed primarily to changes in T2 relaxation times—the rate at which spins lose phase coherence. However, the sequence often suffers from limited specificity, leading researchers to question if other tissue properties are at play. This study investigates the underlying physical mechanisms of T2-STIR contrast, specifically examining the roles of Proton Density (PD) and T1 relaxation in addition to T2.
Methods
The researchers utilized a longitudinal canine model ($n=3$) with induced ischemia-reperfusion injury via LAD occlusion. Imaging was performed at multiple intervals: 2 hours post-injury, and on days 2, 5, and 7. Acquisitions were made on a 1.5T Siemens Espree system.
To isolate the sources of contrast, STIR images were acquired at two different Echo Times (TE):
- Minimum TE (7.1 ms): Designed to minimize T2-weighting, effectively isolating the effects of Proton Density.
- Standard TE (64 ms): The typical setting used for clinical T2-weighting.
These results were validated against T1 and T2 maps to calculate actual relaxation values, while Late Gadolinium Enhancement (LGE) confirmed the exact location of the infarct.
Results and Discussion
The quantitative analysis revealed that Proton Density is a major, often overlooked, driver of contrast in STIR imaging. At a low TE (7.1 ms), where T2 effects are minimal, the edematous territory remained clearly visible. In this configuration, PD changes accounted for 115.9% ± 15.6% of the contrast, effectively proving that edema detection is possible through PD changes alone.
In standard clinical settings (TE = 64 ms), T2 relaxation becomes the dominant factor (86.2% ± 25.7%), but PD still contributes a significant 25.5% ± 17.3% to the total contrast.
The T1 "Antagonist" and Contrast Synergy
A key finding of the study is the role of T1 relaxation. T1 effects were found to act as an "antagonist," contributing negatively to the contrast (-25.3% at low TE and -13.0% at high TE). This means the bright signal observed in clinical practice is the net result of PD and T2 "fighting" against the opposing influence of T1 relaxation.
The visual evidence from the canine model confirms these findings. Even when T2-weighting is minimized, the affected territory appears hyperintense, highlighting the robustness of PD-driven contrast.
Rethinking T2-STIR
The term "T2-STIR" may be partially misleading. The sequence functions as a hybrid, benefiting significantly from increased water content (PD) in swollen tissue, not just the altered magnetic properties (T2) of that water. The study suggests that the mean signal intensity change between healthy and affected tissue was 33.4% at the low TE and 65.7% at the higher TE.
Conclusion
This study demonstrates that the diagnostic power of T2-STIR MRI stems from a combination of Proton Density and T2 relaxation changes. Understanding this multi-parametric nature is crucial for optimizing future imaging sequences. Specifically, methods that focus exclusively on T2-weighting may inadvertently discard valuable diagnostic information provided by Proton Density changes in edematous tissue. Future research should focus on developing MRI sequences that intentionally combine these sources of contrast synergistically to maximize sensitivity and specificity.
Summary updated